Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ImpedimedASX:IPD Operating Cash Flow per Share is A$-0.01 as of Jun. 2026. The stock has 5 warning signs investors should review. Among 651 Medical Devices & Instruments companies, Impedimed ranks worse than 56.07% on this metric.
Impedimed's operating cash flow per share for the
six
months ended in Jun. 2026 was A$-0.00.
Impedimed's operating cash flow per share for the trailing twelve months (TTM) ended in Jun. 2026 was A$-0.01.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 7.20% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 6.80% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 23.60% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.
The historical rank and industry rank for Impedimed's Operating Cash Flow per Share or its related term are showing as below:
ASX:IPD'
s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -26.6 Med: 14.3 Max: 43.2
Current: 7.2
During the past 13 years, Impedimed's highest 3-Year average Operating Cash Flow per Share Growth Rate was 43.20% per year. The lowest was -26.60% per year. And the median was 14.30% per year.
ASX:IPD's 3-Year OCF Growth Rate is ranked worse than 56.07% of 651
companies
in the Medical Devices & Instruments industry
Industry Median: 12.5
vs ASX:IPD: 7.20
Impedimed Operating Cash Flow per Share Related Terms
Impedimed Operating Cash Flow per Share Historical Data
* Premium members only.
The historical data trend for Impedimed's Operating Cash Flow per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:IPD vs ABT, SYK, MDT: Operating Cash Flow per Share Comparison
For the Medical Devices subindustry, Impedimed's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Impedimed Price-to-Operating-Cash-Flow vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Impedimed's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Impedimed's Price-to-Operating-Cash-Flow falls into.
Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.01
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Operating Cash Flow per Share of A$-0.01 mean?
Impedimed (ASX:IPD) has a Operating Cash Flow per Share of A$-0.01 as of Jun. 2026. Operating cash flow per share equals the per-share amount of cash flow from operations. View historical data on Impedimed and its competitors. According to the industry distribution chart, Impedimed ranks #365 out of 651 companies in the Medical Devices & Instruments industry, placing it in the top 56.1%.
Is Impedimed's Operating Cash Flow per Share too high?
Impedimed's current Operating Cash Flow per Share is A$-0.01. Based on the distribution chart, Impedimed ranks #365 out of 651 companies in the Medical Devices & Instruments industry, which is below the industry midpoint.
How does Impedimed's Operating Cash Flow per Share compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Impedimed ranks #365 out of 651 companies for Operating Cash Flow per Share. This places Impedimed in the lower half of its industry. The industry median Operating Cash Flow per Share is 12.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Cash Flow per Share for a Medical Devices & Instruments company?
The median Operating Cash Flow per Share among Medical Devices & Instruments companies is 12.50, based on 651 companies in the industry. Companies in the top quartile (top 25%) have a Operating Cash Flow per Share significantly above this median, while those in the bottom quartile fall well below. However, Operating Cash Flow per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Cash Flow per Share mean?
A high Operating Cash Flow per Share can signal that a stock is expensive relative to its fundamentals. Operating cash flow per share equals the per-share amount of cash flow from operations. View historical data on Impedimed and its competitors. For the Medical Devices & Instruments industry, the median Operating Cash Flow per Share is 12.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Impedimed's current Operating Cash Flow per Share is A$-0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Impedimed stock overvalued right now?
Based on GuruFocus' analysis, Impedimed (ASX:IPD) is currently considered Possible Value Trap. The stock's GF Value™ is A$0.07, compared to a current price of A$0.01 — trading 92.9% below its estimated fair value. The current Operating Cash Flow per Share is A$-0.01. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Cash Flow per Share calculated?
Operating Cash Flow per Share is calculated from a company's financial statements. For Impedimed (ASX:IPD), the current Operating Cash Flow per Share is A$-0.01 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Impedimed Ltd, together with its subsidiaries, operates in the medical devices space. The company is based in Australia and operates globally, and it generates the majority of its revenue in North America. It is engaged in developing, manufacturing, and distributing noninvasive medical devices. The company offers products that are typically used to assess and monitor lymphedema and heart failure, as well as to measure the tissue composition and fluid status of the patients. The company also offers a cloud-based digital platform (branded as SOZO) to manage patient data. The company recognises revenue from the stand-alone sale of Legacy Devices and Consumables, the Sale of SOZO Devices, and Software Subscription Services.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:IPD has been successfully added to your 
